Gharabawy Ramez, Abd-Elsayed Alaa, Elsharkawy Hesham, Farag Ehab, Cummings Kenneth, Eid Gamal, Mendoza Maria, Mounir-Soliman Loran, Rosenquist Richard, Ali Sakr Esa Wael
Anesthesiology, Cleveland Clinic, 9500 Euclid Avenue, E-31, Cleveland, OH 44195, USA.
Anesthesiology Department, University of Cincinnati, 231 Albert Sabin Way, Cincinnati, OH 45267-0531, USA ; Anesthesiology Department, University of Wisconsin School of Medicine and Public Health, 600 Highland Avenue, Madison, WI 53792-3272, USA.
ScientificWorldJournal. 2014;2014:572507. doi: 10.1155/2014/572507. Epub 2014 Apr 2.
Continuous peripheral nerve blocks (CPNB) are commonly used for intraoperative and postoperative analgesia. Our study aimed at describing our experience with ambulatory peripheral nerve catheters. After Institutional Review Board approval, records for all patients discharged with supraclavicular or popliteal catheters between January 1, 2009 and December 31, 2011 were reviewed. A licensed practitioner provided verbal and written instructions to the patients prior to discharge. Daily follow-up phone calls were conducted. Patients either removed their catheters at home with real-time simultaneous telephone guidance by a member of the Acute Pain Service or had them removed by the surgeon during a regular office visit. The primary outcome of this analysis was the incidence of complications, categorized as pharmacologic, infectious, or other. The secondary outcome measure was the average daily pain score. Our study included a total of 1059 patients with ambulatory catheters (769 supraclavicular, 290 popliteal). The median infusion duration was 5 days for both groups. Forty-two possible complications were identified: 13 infectious, 23 pharmacologic, and 6 labeled as other. Two patients had retained catheters, 2 had catheter leakage, and 2 had shortness of breath. Our study showed that prolonged use of ambulatory catheters for a median period of 5 days did not lead to an increased incidence of complications.
连续外周神经阻滞(CPNB)常用于术中及术后镇痛。我们的研究旨在描述我们在门诊外周神经导管方面的经验。经机构审查委员会批准后,回顾了2009年1月1日至2011年12月31日期间所有携带锁骨上或腘窝导管出院的患者记录。在出院前,有执照的从业者向患者提供了口头和书面指导。每天进行随访电话。患者要么在急性疼痛服务团队成员的实时电话指导下在家自行拔除导管,要么在外科医生的常规门诊就诊时由外科医生拔除导管。该分析的主要结果是并发症的发生率,分为药物性、感染性或其他类型。次要结果指标是平均每日疼痛评分。我们的研究共纳入了1059例携带门诊导管的患者(769例锁骨上导管,290例腘窝导管)。两组的中位输注持续时间均为5天。共识别出42例可能的并发症:13例感染性、23例药物性和6例其他类型。2例患者导管留置,2例导管渗漏,2例呼吸急促。我们的研究表明,门诊导管中位使用时间延长至5天并未导致并发症发生率增加。